Innovita Biological Technology Co., Ltd. (SHA:688253)
31.78
+1.03 (3.35%)
At close: Oct 31, 2025
SHA:688253 Revenue
Innovita Biological Technology had revenue of 53.97M CNY in the quarter ending September 30, 2025, a decrease of -45.90%. This brings the company's revenue in the last twelve months to 430.96M, down -40.18% year-over-year. In the year 2024, Innovita Biological Technology had annual revenue of 621.39M with 29.99% growth.
Revenue (ttm)
430.96M
Revenue Growth
-40.18%
P/S Ratio
10.01
Revenue / Employee
772.34K
Employees
547
Market Cap
4.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 621.39M | 143.37M | 29.99% |
| Dec 31, 2023 | 478.02M | 31.40M | 7.03% |
| Dec 31, 2022 | 446.62M | 119.71M | 36.62% |
| Dec 31, 2021 | 326.91M | -710.19M | -68.48% |
| Dec 31, 2020 | 1.04B | 899.09M | 651.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |